Remicade Biosimilars Market on Muck Rack

Remicade Biosimilars Market

As seen in: GlobeNewswire, MENAFN, Global information inc
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Remicade Biosimilars

Contact Remicade Biosimilars, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Biosimilars - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

|
By Real-World Evidence, Manufacturing Type, Remicade Biosimilars Market
| Global information inc
According to Mordor Intelligence, the biosimilars market size is expected to increase from USD 41.97 billion in 2025 to USD 49.49 billion in 2026 and reach USD 112.93 billion by 2031, growing at a CAGR of 17.95% over 2026-2031.
Open in Who Shared Issue with article?

Remicade Biosimilars Market Size & Share to Exceed USD 34.4 Original

|
By Remicade Biosimilars Market
| GlobeNewswire
Covina, Feb. 08, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Remicade Biosimilars Market size was valued at about USD 15.3 Billion in 2024 and expected to grow at CAGR of 9.30% to extend a value of USD 34.4 Billion by 2034.” What is Remicade Biosimilars? Market Overview: Remicade biologic functions by inhibiting the action of TNF-alpha, a protein involved in inflammation, as it is a tumor necrosis factor (TNF) alpha inhibitor.
Open in Who Shared View Duplicates (9) Issue with article?
See all 3 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified